ecancermedicalscience

Policy

Cancer disease progression and death during the COVID-19 pandemic: a multidisciplinary analysis for the Peruvian setting

8 Sep 2020
Juan Astigueta-Pérez, Milagros Abad-Licham, Carlos Chávez-Chirinos, Luis Beraun-Milla, Alberto Lachos-Dávila, Elizabeth Diaz-Pérez, Karem Portugal-Valdivia, Paul Pilco Castañeda, Isaías Pérez Alférez, Edward Mezones-Holguín

Since the COVID-19 pandemic began in China in late 2019, infection from the SARS-CoV-2 virus has spread virtually worldwide. This infection has adversely affected several countries; governments have outlined a series of political measures aimed to preserve the health and safety of their populations. In Peru, most actions have prioritised COVID-19 attention, with a subsequent gap in the healthcare facilities needed for other diseases. Cancer, one principal cause of death in the country, is usually diagnosed late. Moreover, in the pandemic context, the prevention and control of cancer have been negatively affected. Therefore, we carried out a multidisciplinary analysis using the Ishikawa diagram to identify the probable factors that contribute to cancer progression and deaths in Peru.

Related Articles

Leonardo G Da Fonseca, Duilio Reis da Rocha Filho, Aline Lopes Chagas, Alexandre Jacome, Leila Moreira Beltrao Pereira, Rogerio Alves, Mario Reis Alvares-da-Silva, Mauro Donadio, Ana Paula Victorino, Federico Piñero, Cassia Guedes Leal
Olufemi Abiola Oyedeji, Ayoola Moses Bakare, Nosimot Omolola Davies, Olusola Festus Olowoselu, Ann Abiola Ogbenna
Zakayo Ernesti, Emanuel Lugina, Chacha J Mwita, Felister Tupa, Herriethsiah S Noah, John R Ngowi, Charles Wood, Julius Mwaiselage, Salum J Lidenge
Neha Singh, Sujata Agrawal, Zachariah Chowdhury, Shashikant Patne, Ipsita Dhal, Paramita Paul, Sadaf Haiyat, Akhil Kapoor, Anuj Gupta, Bal Krishna Mishra, Mayank Tripathi, Bipinesh Sansar
Edwin Saji, Jason Jacob, Udaya Kumar Damodaran, Sabah Kulsum, Sharanya Tripathi, Akshat Saxena, Panah Parab, Utkarsh Dayal, Priyal Dilip Mehta, Aju Mathew